| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7db23a3fe5d392e2dd35e3f45e9d4468 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2001-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eac449e58fd96768f38b72e879b57baa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_398f2545584a45d18907c58384acf8f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_065b21e3658737720f93eeab8049aeaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d41795a7da0e0858ec84d5eb5dc5f3e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fc036db6e6f46807de1009b8e4f453a |
| publicationDate |
2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-522016-A |
| titleOfInvention |
Formulation having mobilising activity |
| abstract |
A formulation containing as active agents defibrotide and at least one haematopoietic factor having the capacity to mobilize haematopoietic progenitors such as G-CSF; and the use of defibrotide in combination with at least one haematopoietic factor having the capacity to mobilize haematopoietic progenitors for the preparation of formulations capable of increasing the amount of stem cells and/or haematopoietic progenitors in the peripheral blood of a mammal. |
| priorityDate |
2000-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |